What it is
Trigeminal neuralgia is a disorder of the fifth cranial nerve — the trigeminal nerve — that produces some of the most severe pain a human being can experience. Episodes are brief, often lasting only seconds, but they can occur dozens of times per day and are triggered by the most ordinary activities: eating, speaking, touching the face.
The most common cause is a blood vessel — usually an artery — pressing on the trigeminal nerve at the point where it enters the brainstem. Over time this contact damages the myelin sheath around the nerve and disrupts normal signaling.
Medical management
Carbamazepine is the gold-standard first-line medication and is effective for most patients early in the course of disease. Over time, the condition tends to progress and medications lose efficacy, or side effects become limiting. When medications no longer control pain adequately, procedural options become appropriate.
Procedural options
Three well-established approaches exist:
- Microvascular decompression (MVD) — open surgery to separate the offending blood vessel from the nerve with a small cushion. The most durable option, with high long-term pain relief rates. Best suited for medically fit patients who want the most lasting result.
- Stereotactic radiosurgery (Gamma Knife) — focused radiation delivered to the nerve root. Non-invasive, done in a single session. Effective but typically takes weeks to months to provide relief, and long-term durability is somewhat lower than MVD.
- Percutaneous procedures (balloon compression, glycerol rhizotomy, radiofrequency thermocoagulation) — done through a needle in the cheek under light sedation. Provide relief quickly and can be repeated if pain recurs. Sensory numbness is a predictable trade-off.
The right choice depends on age, medical fitness, patient preference, and prior treatment history. All options are worth discussing in detail.